Related Experiment Videos
Treatment of hypertension with hydrochlorothiazide and spironolactone
Insights
Hydrochlorothiazide (HCT) and spironolactone (SL) showed similar antihypertensive effects in patients with essential hypertension. Combined therapy did not further reduce blood pressure but increased blood urea nitrogen.
Area of Science:
- Cardiology
- Pharmacology
- Nephrology
Background:
- Essential hypertension is a common condition requiring effective treatment.
- Diuretics like hydrochlorothiazide and spironolactone are frequently used antihypertensive agents.
- Understanding the comparative efficacy and side effects of these drugs is crucial for clinical practice.
Purpose of the Study:
- To compare the antihypertensive efficacy of hydrochlorothiazide (HCT) and spironolactone (SL).
- To evaluate the effects of combined HCT and SL therapy.
- To assess the impact of these treatments on blood urea nitrogen and serum sodium levels.
Main Methods:
- A comparative study involving 48 patients with essential hypertension.
- Patients received either 150 mg of HCT or 150 mg of SL daily for six weeks.
- A subset of 25 patients received combined therapy.
Main Results:
- No significant difference in blood pressure reduction was observed between HCT and SL monotherapy after six weeks.
- Combined HCT and SL treatment did not yield further blood pressure reduction.
- Both HCT and SL increased blood urea nitrogen concentrations.
- Combined therapy led to a further increase in blood urea nitrogen and a decrease in serum sodium levels.
Conclusions:
- Hydrochlorothiazide and spironolactone demonstrate comparable antihypertensive effects in essential hypertension.
- Combination therapy does not offer additional blood pressure benefits but may exacerbate changes in renal function and electrolytes.
- Further investigation into the long-term effects and optimal use of these agents is warranted.
Abstract:
A comparison was made of the antihypertensive effect of a daily dose of 150 mg. of hydrochlorothiazide (HCT) with one of 150 mg. of spironolactone (SL) in 48 patients with essential hypertension.The blood pressure values after six weeks of therapy with HCT were not significantly different from those after SL. Treatment of 25 of these patients with the two agents combined did not reduce the blood pressure further. Blood urea nitrogen concentrations increased with both HCT and SL treatment.With combined treatment there was a further increase in blood urea nitrogen concentration and a decrease in serum sodium concentrations without weight loss beyond that achieved with either HCT or SL alone.